Back to Search
Start Over
Vaccine development and passive immunization for Pseudomonas aeruginosa in critically ill patients: a clinical update
- Source :
- Future Microbiology. 9:457-463
- Publication Year :
- 2014
- Publisher :
- Future Medicine Ltd, 2014.
-
Abstract
- ABSTRACT: Pseudomonas aeruginosa is one of the most common causes of nosocomial infection in intensive care unit patients and is independently associated with worse outcomes. Resistance of P. aeruginosa to antimicrobial agents is increasingly common and treatment of these infections is a growing challenge for intensivists. The development of methods to prevent infection, such as vaccines, is thus of considerable interest. Three agents currently show promise in this population of patients and are undergoing clinical evaluation; however, further vaccine targets are being discovered and more potential agents will likely be developed in the near future.
- Subjects :
- Microbiology (medical)
medicine.medical_specialty
Pseudomonas Vaccines
Critical Illness
Population
medicine.disease_cause
Microbiology
law.invention
Sepsis
Antibiotic resistance
law
medicine
Humans
Pseudomonas Infections
Intensive care medicine
education
Clinical Trials as Topic
Cross Infection
education.field_of_study
Pseudomonas aeruginosa
business.industry
Immunization, Passive
Antimicrobial
medicine.disease
Intensive care unit
Vaccination
Intensive Care Units
Immunization
business
Subjects
Details
- ISSN :
- 17460921 and 17460913
- Volume :
- 9
- Database :
- OpenAIRE
- Journal :
- Future Microbiology
- Accession number :
- edsair.doi.dedup.....7ab44287eeef4f242351c3c29142bf36